When is the second dose of hepatitis B (HB) vaccine administered to an infant born to a hepatitis B surface antigen (HBsAg)-positive mother?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis B Vaccination Schedule for Infants Born to HBsAg-Positive Mothers

The second dose of hepatitis B vaccine for an infant born to an HBsAg-positive mother should be administered at 1 month of age (option B). 1

Complete Vaccination Schedule for Infants Born to HBsAg-Positive Mothers

The CDC-recommended vaccination schedule for these high-risk infants includes:

  1. First dose: At birth (within 12 hours of life), along with HBIG at a different injection site 1, 2
  2. Second dose: At 1-2 months of age 1
  3. Third dose: At 6 months of age 1

For infants weighing less than 2,000 grams at birth, a 4-dose schedule is recommended:

  • Birth
  • 1 month
  • 2-3 months
  • 6 months 1

Important Clinical Considerations

Administration Details

  • Only monovalent hepatitis B vaccine should be used for the birth dose 1
  • HBIG (0.5 mL) should be administered intramuscularly to the newborn preferably within 12 hours of birth 2
  • HBIG efficacy decreases markedly if treatment is delayed beyond 48 hours 2
  • The first dose of vaccine may be given concurrently with HBIG but at a separate injection site 2

Follow-up Testing

  • Postvaccination serologic testing (PVST) should be performed at age 9-12 months (or 1-2 months after the final vaccine dose if delayed) 1, 3
  • Testing should include both HBsAg and anti-HBs levels 1
  • Testing should not be performed before 9 months to avoid detection of passive antibodies from HBIG 1

Common Pitfalls to Avoid

  1. Delayed second dose: Research suggests that delaying the second dose beyond 10 weeks increases the risk of chronic HBV infection by 3.74 times in infants born to chronically HBV infected mothers 4

  2. Inadequate follow-up: Ensure completion of the full vaccine series and appropriate serological testing to confirm protection 1

  3. Communication gaps: When infants are transferred between facilities, clear communication about vaccination and HBIG status is essential to prevent errors 1

  4. Low birth weight considerations: Infants with birth weights <2000g have lower seroprotection rates when vaccinated in the first few days of life compared to those vaccinated at 1 month or older (68% vs. 95%) 5

The timely administration of both HBIG and the complete hepatitis B vaccine series is critical for preventing perinatal HBV transmission and the development of chronic hepatitis B infection in these high-risk infants.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.